MedPath

Clinical study of the administration method of antithrombin agent

Not Applicable
Recruiting
Conditions
sepsis indused disseminated intravascular coagulation
Registration Number
JPRN-UMIN000018280
Lead Sponsor
Tokyo women's medical university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. other DIC agent for DIC treatment 2. use of anticoagulants, antiplatelet agents, antithrombotics, exception of heparin locks, heparin flushes or deep-vein thrombosis prophykaxis, and anticoaglants for renal replacement therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disseminated intravascular coagulation resolution rates
Secondary Outcome Measures
NameTimeMethod
28-day survival rate, AT activity change
© Copyright 2025. All Rights Reserved by MedPath